Prebiotic properties of galursan HF 7K on mouse gut microbiota

Cellular Physiology and Biochemistry

Volumn 32, Issue 7, 2013, Pages 96-110

  Engevik, Melinda A ^a,b   Faletti, Carla J ^c   Paulmichl, Markus ^c   Worrell, Roger T ^a,b  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^c PARACELSUS MEDICAL UNIVERSITY   (Austria)

Author keywords

Antibiotics; Diarrhea; Intestine; Sugars

Indexed keywords

GALURSAN HF 7K; PREBIOTIC AGENT; UNCLASSIFIED DRUG; GENOMIC DNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BIFIDOBACTERIUM; BODY WEIGHT; CONTROLLED STUDY; DESCENDING COLON; DIET SUPPLEMENTATION; DUODENUM; FLUID INTAKE; FOOD INTAKE; INTESTINE FLORA; INTESTINE FLUID; JEJUNUM; LACTOBACILLUS; MOUSE; NONHUMAN; PRIORITY JOURNAL; ACTINOBACTERIA; AUSTRIA; BACTERIAL LOAD; BACTERIAL TRANSLOCATION; BACTEROIDETES; CECUM; CELL INTERACTION; FIRMICUTES; FOWL; FUSOBACTERIA; GENE AMPLIFICATION; INTESTINAL REABSORPTION; PROTEOBACTERIA; REAL TIME POLYMERASE CHAIN REACTION; WEIGHT GAIN;

BACTERIA (MICROORGANISMS); BIFIDOBACTERIUM; DAUCUS CAROTA; FIRMICUTES; LACTOBACILLUS; MUS; PROTEOBACTERIA;

ANIMALS; ANTI-BACTERIAL AGENTS; BACTERIA; BODY WEIGHT; DIETARY SUPPLEMENTS; INTESTINES; MICE; MICROBIOTA; PIPEMIDIC ACID; PREBIOTICS;

EID: 84892946774     PISSN: 10158987     EISSN: 14219778     Source Type: Journal    
DOI: 10.1159/000356631     Document Type: Article

References (108)

1. Qin J, Li R, Raes J, Arumugam M, Burgdorf KS, Manichanh C, Nielsen T, Pons N, Levenez F, Yamada T, Mende DR, Li J, Xu J, Li S, Li D, Cao J, Wang B, Liang H, Zheng H, Xie Y, Tap J, Lepage P, Bertalan M, Batto JM, Hansen T, Le Paslier D, Linneberg A, Nielsen HB, Pelletier E, Renault P, Sicheritz-Ponten T, Turner K, Zhu H, Yu C, Li S, Jian M, Zhou Y, Li Y, Zhang X, Li S, Qin N, Yang H, Wang J, Brunak S, Dore J, Guarner F, Kristiansen K, Pedersen O, Parkhill J, Weissenbach J, Meta HITC, Bork P, Ehrlich SD, Wang J: A human gut microbial gene catalogue established by metagenomic sequencing. Nature 2010;464:59-65.
2. Backhed F, Ley RE, Sonnenburg JL, Peterson DA, Gordon JI: Host-bacterial mutualism in the human intestine. Science 2005;307:1915-1920.
3. Matsumoto M, Kurihara S, Kibe R, Ashida H, Benno Y: Longevity in mice is promoted by probiotic-induced suppression of colonic senescence dependent on upregulation of gut bacterial polyamine production. PLOS ONE 2001;6:e23652-e23663.
4. Patrick DM, Marra F, Hutchinson J, Monnet DL, Ng H, Bowie WR: Per capita antibiotic consumption: How does a North American jurisdiction compare with Europe? Clin Infect Dis 2004;39:11-17.
5. Mathew AG, Cissell R, Liamthong S: Antibiotic resistance in bacteria associated with food animals: A United States perspective of livestock production. Foodborne Pathog Dis 2007;4:115-133.
6. Abou-Youssef MH, DiCuollo CJ, Miller CR, Scott GC: Influence of a sub-therapeutic level of virginiamycin in feed on the incidence and persistence of salmonella typhimurium in experimentally infected swine. J Anim Sci 1979;49:128-133.
7. Barrow PA, Lovell MA, Szmolleny G, Murphy CK: Effect of enrofloxacin administration on excretion of salmonella ententidis by experimentally infected chickens and on quinolone resistance of their Escherichia coli flora. Avian Pathol 1998;27:586-590.
8. Mathers JJ, Clark SR, Hausmann D, Tillman P, Benning VR, Gordon SK: Inhibition of resistance plasmid transfer in escherichia coli by ionophores, chlortetracycline, bacitracin, and ionophore/antimicrobial combinations. Avian Dis 2004;48:317-323.
9. Chadfield MS, Hinton MH: Evaluation of treatment and prophylaxis with nitrofurans and comparison with alternative antimicrobial agents in experimental salmonella enterica serovar enteritidis infection in chicks. Vet Res Commun 2003;27:257-273.
10. Callaway TR, Anderson RC, Genovese KJ, Poole TL, Anderson TJ, Byrd JA, Kubena LF, Nisbet DJ: Sodium chlorate supplementation reduces E. Coli o157:H7 populations in cattle. J Anim Sci 2002;80:1683-1689.
11. Antonopoulos DA, Huse SM, Morrison HG, Schmidt TM, Sogin ML, Young VB: Reproducible community dynamics of the gastrointestinal microbiota following antibiotic perturbation. Infect Immun 2009;77:2367-2375.
12. Sekirov I, Tam NM, Jogova M, Robertson ML, Li Y, Lupp C, Finlay BB: Antibiotic-induced perturbations of the intestinal microbiota alter host susceptibility to enteric infection. Infect Immun 2008;76:4726-4736.
13. Jernberg C, Lofmark S, Edlund C, Jansson JK: Long-term impacts of antibiotic exposure on the human intestinal microbiota. Microbiology 2010;156:3216-3223.
14. Hazenberg MP, Van de Boom M, Bakker M, Van de Merwe JP: Effect of antibiotics on the human intestinal flora in mice. Antonie Van Leeuwenhoek 1983;49:97-109.
15. Dethlefsen L, Huse S, Sogin ML, Relman DA: The pervasive effects of an antibiotic on the human gut microbiota, as revealed by deep 16s rRNA sequencing. PLoS Biol 2008;6:e280.
16. Manichanh C, Reeder J, Gibert P, Varela E, Llopis M, Antolin M, Guigo R, Knight R, Guarner F: Reshaping the gut microbiome with bacterial transplantation and antibiotic intake. Genome Res 2010;20:1411-1419.
17. Biernasiak J, Slizewska K, Libudzisz Z: Feeds with probiotics in animals' nutrition, soybean and nutrition; in El-Shemy H(eds): Soybean and Nutrition. InTech, 2011, pp 181-200.
18. Neyrinck AM, Possemiers S, Druart C, Van de Wiele T, De Backer F, Cani PD, Larondelle Y, Delzenne NM: Prebiotic effects of wheat arabinoxylan related to the increase in bifidobacteria, Roseburia and Bacteroides/Prevotella in diet-induced obese mice. PLoS One 2011;6:e20944.
19. Roberfroid M, Gibson GR, Hoyles L, McCartney AL, Rastall R, Rowland I, Wolvers D, Watzl B, Szajewska H, Stahl B, Guarner F, Respondek F, Whelan K, Coxam V, Davicco MJ, Leotoing L, Wittrant Y, Delzenne NM, Cani PD, Neyrinck AM, Meheust A: Prebiotic effects: Metabolic and health benefits. Br J Nutr 2010;104:S1-63.
20. Sousa VMCd, dos Santos EF, Sgarbieri VC: The importance of prebiotics in functional foods and clinical practice. Food Nutr Sci, 2011;2:133-144.
21. Roberfroid M, Slavin J: Nondigestible oligosaccharides. Crit Rev Food Sci Nutr 2000;40:461-480.
22. Biol MC, Martin A, Oehninger C, Louisot P, Richard M: Biosynthesis of glycoproteins in the intestinal mucosa. II. Influence of diets. Ann Nutr Metab 1981;25:269-280.
23. Cani PD, Hoste S, Guiot Y, Delzenne NM: Dietary non-digestible carbohydrates promote L-cell differentiation in the proximal colon of rats. Br J Nutr 2007;98:32-37.
24. Saier MH, Jr., Mansour NM: Probiotics and prebiotics in human health. J Mol Microbiol Biotechnol 2005;10:22-25.
25. Bosscher D, Van Loo J, Franck A: Inulin and oligofructose as prebiotics in the prevention of intestinal infections and diseases. Nutr Res Rev 2006;19:216-226.
26. Gibson GR, Fuller R: Aspects of in vitro and in vivo research approaches directed toward identifying probiotics and prebiotics for human use. J Nutr 2000;130:391S-395S.
27. Weirich A, Hoffmann GF: Ernst moro (1874-1951)-a great pediatric career started at the rise of university-based pediatric research but was curtailed in the shadows of Nazi laws. Eur J Pediatr 2005;164:599-606.
28. Kunz C: Historical aspects of human milk oligosaccharides. Adv Nutr 2012;3:430S-439S.
29. Taketo M, Schroeder AC, Mobraaten LE, Gunning KB, Hanten G, Fox RR, Roderick TH, Stewart CL, Lilly F, Hansen CT, et al.: FVB/N: An inbred mouse strain preferable for transgenic analyses. Proc Natl Acad Sci USA 1991;88:2065-2069.
30. Engevik MA, Aihara E, Montrose MH, Shull GE, Hassett DJ, Worrell RT: Loss of NHE3 alters gut microbiota composition and influences bacteroides thetaiotaomicron growth. Am J Physiol Gastrointest Liver Physiol 2013;305:G697-711.
31. Frantz AL, Rogier EW, Weber CR, Shen L, Cohen DA, Fenton LA, Bruno ME, Kaetzel CS: Targeted deletion of MyD88 in intestinal epithelial cells results in compromised antibacterial immunity associated with downregulation of polymeric immunoglobulin receptor, mucin-2, and antibacterial peptides. Mucosal Immunol 2012;5:501-512.
32. IJssennagger N, Derrien M, van Doorn GM, Rijnierse A, van den Bogert B, Muller M, Dekker J, Kleerebezem M, van der Meer R: Dietary heme alters microbiota and mucosa of mouse colon without functional changes in host-microbe cross-talk. PLoS One 2012;7:e49868.
33. Norkina O, Burnett TG, De Lisle RC: Bacterial overgrowth in the cystic fibrosis transmembrane conductance regulator null mouse small intestine. Infect Immun 2004;72:6040-6049.
34. Caldwell DR, Arcand C: Inorganic and metal-organic growth requirements of the genus Bacteroides. J Bacteriol 1974;120:322-333.
35. Caldwell DR, Keeney M, Barton JS, Kelley JF: Sodium and other inorganic growth requirements of bacteroides amylophilus. J Bacteriol 1973;114:782-789.
36. Hooper LV, Falk PG, Gordon JI: Analyzing the molecular foundations of commensalism in the mouse intestine. Curr Opin Microbiol 2000;3:79-85.
37. Castillo NA, de Moreno de LeBlanc A, C MG, Perdigon G: Comparative study of the protective capacity against Salmonella infection between probiotic and nonprobiotic Lactobacilli. J Appl Microbiol 2013;114:861-876.
38. Salzman NH, Hung K, Haribhai D, Chu H, Karlsson-Sjoberg J, Amir E, Teggatz P, Barman M, Hayward M, Eastwood D, Stoel M, Zhou Y, Sodergren E, Weinstock GM, Bevins CL, Williams CB, Bos NA: Enteric defensins are essential regulators of intestinal microbial ecology. Nat Immunol 2010;11:76-83.
39. Barman M, Unold D, Shifley K, Amir E, Hung K, Bos N, Salzman N: Enteric salmonellosis disrupts the microbial ecology of the murine gastrointestinal tract. Infect Immun 2008;76:907-915.
40. Berg RD: Mechanisms promoting bacterial translocation from the gastrointestinal tract. J Med 1992;23:217-244.
41. Amar J, Chabo C, Waget A, Klopp P, Vachoux C, Bermudez-Humaran LG, Smirnova N, Berge M, Sulpice T, Lahtinen S, Ouwehand A, Langella P, Rautonen N, Sansonetti PJ, Burcelin R: Intestinal mucosal adherence and translocation of commensal bacteria at the early onset of type 2 diabetes: Molecular mechanisms and probiotic treatment. EMBO Mol Med 2011;3:559-572.
42. Chichlowski M, Hale LP: Bacterial-mucosal interactions in inflammatory bowel disease: An alliance gone bad. Am J Physiol Gastrointest Liver Physiol 2008;295:G1139-1149.
43. Zaidel O, Lin HC: Uninvited guests: The impact of small intestinal bacterial overgrowth on nutritional status. Practical Gastroenterology 2003;7:27-34.
44. Naaber P, Mikelsaar RH, Salminen S, Mikelsaar M: Bacterial translocation, intestinal microflora and morphological changes of intestinal mucosa in experimental models of Clostridium difficile infection. J Med Microbiol 1998;47:591-598.
45. Quigley EM, Quera R: Small intestinal bacterial overgrowth: Roles of antibiotics, prebiotics, and probiotics. Gastroenterology 2006;130:S78-90.
46. Swidsinski A, Ladhoff A, Pernthaler A, Swidsinski S, Loening-Baucke V, Ortner M, Weber J, Hoffmann U, Schreiber S, Dietel M, Lochs H: Mucosal flora in inflammatory bowel disease. Gastroenterology 2002;122:44-54.
47. Guarner F, Malagelada JR: Gut flora in health and disease. Lancet 2003;361:512-519.
48. Suau A, Bonnet R, Sutren M, Godon JJ, Gibson GR, Collins MD, Dore J: Direct analysis of genes encoding 16s rRNA from complex communities reveals many novel molecular species within the human gut. Appl Environ Microbiol 1999;65:4799-4807.
49. Eckburg PB, Bik EM, Bernstein CN, Purdom E, Dethlefsen L, Sargent M, Gill SR, Nelson KE, Relman DA: Diversity of the human intestinal microbial flora. Science 2005;308:1635-1638.
50. Ley RE, Hamady M, Lozupone C, Turnbaugh PJ, Ramey RR, Bircher JS, Schlegel ML, Tucker TA, Schrenzel MD, Knight R, Gordon JI: Evolution of mammals and their gut microbes. Science 2008;320:1647-1651.
51. Ley RE, Turnbaugh PJ, Klein S, Gordon JI: Microbial ecology: Human gut microbes associated with obesity. Nature 2006;444:1022-1023.
52. Zoetendal EG, von Wright A, Vilpponen-Salmela T, Ben-Amor K, Akkermans AD, de Vos WM: Mucosa-associated bacteria in the human gastrointestinal tract are uniformly distributed along the colon and differ from the community recovered from feces. Appl Environ Microbiol 2002;68:3401-3407.
53. Sghir A, Gramet G, Suau A, Rochet V, Pochart P, Dore J: Quantification of bacterial groups within human fecal flora by oligonucleotide probe hybridization. Appl Environ Microbiol 2000;66:2263-2266.
54. Williams KP, Gillespie JJ, Sobral BW, Nordberg EK, Snyder EE, Shallom JM, Dickerman AW: Phylogeny of gammaproteobacteria. J Bacteriol 2010;192:2305-2314.
55. Croswell A, Amir E, Teggatz P, Barman M, Salzman NH: Prolonged impact of antibiotics on intestinal microbial ecology and susceptibility to enteric Salmonella infection. Infect Immun 2009;77:2741-2753.
56. Young VB, Schmidt TM: Antibiotic-associated diarrhea accompanied by large-scale alterations in the composition of the fecal microbiota. J Clin Microbiol 2004;42:1203-1206.
57. Mozes S, Sefcikova Z, Bujnakova D, Racek L: Effect of antibiotic treatment on intestinal microbial and enzymatic development in postnatally overfed obese rats. Obesity (Silver Spring) 2013;21:1635-1642.
58. Kheadr E, Dabour N, Le Lay C, Lacroix C, Fliss I: Antibiotic susceptibility profile of bifidobacteria as affected by oxgall, acid, and hydrogen peroxide stress. Antimicrob Agents Chemother 2007;51:169-174.
59. Moubareck C, Gavini F, Vaugien L, Butel MJ, Doucet-Populaire F: Antimicrobial susceptibility of bifidobacteria. J Antimicrob Chemother 2005;55:38-44.
60. Hussey S, Wall R, Gruffman E, O'Sullivan L, Ryan CA, Murphy B, Fitzgerald G, Stanton C, Ross RP: Parenteral antibiotics reduce bifidobacteria colonization and diversity in neonates. Int J Microbiol 2011;2011
61. Kibe R, Sakamoto M, Yokota H, Benno Y: Characterization of the inhabitancy of mouse intestinal bacteria (MIB) in rodents and humans by real-time PCR with group-specific primers. Microbiol Immunol 2007;51:349-357.
62. Dunne C: Adaptation of bacteria to the intestinal niche: Probiotics and gut disorder. Inflamm Bowel Dis 2001;7:136-145.
63. Dunne C, O'Mahony L, Murphy L, Thornton G, Morrissey D, O'Halloran S, Feeney M, Flynn S, Fitzgerald G, Daly C, Kiely B, O'Sullivan GC, Shanahan F, Collins JK: In vitro selection criteria for probiotic bacteria of human origin: Correlation with in vivo findings. Am J Clin Nutr 2001;73:386S-392S.
64. Dunne C, Murphy L, Flynn S, O'Mahony L, O'Halloran S, Feeney M, Morrissey D, Thornton G, Fitzgerald G, Daly C, Kiely B, Quigley EM, O'Sullivan GC, Shanahan F, Collins JK: Probiotics: From myth to reality. Demonstration of functionality in animal models of disease and in human clinical trials. Antonie Van Leeuwenhoek 1999;76:279-292.
65. Klein G, Pack A, Bonaparte C, Reuter G: Taxonomy and physiology of probiotic lactic acid bacteria. Int J Food Microbiol 1998;41:103-125.
66. Sanders ME: Overview of functional foods: Emphasis on probiotic bacteria. Int Dairy J 1998;8:341-347.
67. Gomes A, Malcata F: Bifidobacterium spp. and Lactobacillus acidophilus: Biological, biochemical, technological and therapeutical properties relevant for use as probiotics. Trends Food SciTechnol 1999;10:139-157.
68. Saxelin M, Grenov B, Svensson U, Fonden R, Reniero R, Mattila-Sandholm T: The technology of probiotics. Trends Food Sci Technol 1999;10.
69. Ouwehand AC, Kirjavainen PV, Shortt C, Salminen S: Probiotics: Mechanisms and established effects. International Dairy Journal 1999;9:43-52.
70. Vaughan EE, Mollet B: Probiotics in the new millennium. Nahrung 1999;43:148-153.
71. Millar MR, Bacon C, Smith SL, Walker V, Hall MA: Enteral feeding of premature infants with lactobacillus GG. Arch Dis Child 1993;69:483-487.
72. Sepp E, Mikelsaar M, Salminen S: Effect of administration of Lactobacillus casei strain GG on the gastrointestinal microbiota of newborns. Microb Ecol Health Dis 1993;6:309-314.
73. Isolauri E, Juntunen M, Rautanen T, Sillanaukee P, Koivula T: A human Lactobacillus strain (Lactobacillus casei sp strain GG) promotes recovery from acute diarrhea in children. Pediatrics 1991;88:90-97.
74. Isolauri E: Probiotics and gut inflammation. Curr Opin Gastroenterol 1999;15:534-537.
75. Dani C, Biadaioli R, Bertini G, Martelli E, Rubaltelli FF: Probiotics feeding in prevention of urinary tract infection, bacterial sepsis and necrotizing enterocolitis in preterm infants. A prospective double-blind study. Biol Neonate 2002;82:103-108.
76. Donnelly GA, Lu J, Takeda T, McKay DM: Colonic epithelial physiology is altered in response to the bacterial superantigen Yersinia pseudotuberculosis mitogen. J Infect Dis 1999;180:1590-1596.
77. Li HS, Doyle WJ, Swarts JD, Hebda PA: Suppression of epithelial ion transport transcripts during pneumococcal acute otitis media in the rat. Acta Otolaryngol 2002;122:488-494.
78. Borenshtein D, Schlieper KA, Rickman BH, Chapman JM, Schweinfest CW, Fox JG, Schauer DB: Decreased expression of colonic Slc26a3 and carbonic anhydrase iv as a cause of fatal infectious diarrhea in mice. Infect Immun 2009;77:3639-3650.
79. Thomsson KA, Hinojosa-Kurtzberg M, Axelsson KA, Domino SE, Lowe JB, Gendler SJ, Hansson GC: Intestinal mucins from cystic fibrosis mice show increased fucosylation due to an induced Fucalpha1-2 glycosyltransferase. Biochem J 2002;367:609-616.
80. Thiru S, Devereux G, King A: Abnormal fucosylation of ileal mucus in cystic fibrosis: I. A histochemical study using peroxidase labelled lectins. J Clin Pathol 1990;43:1014-1018.
81. Lynch SV, Goldfarb KC, Wild YK, Kong W, De Lisle RC, Brodie EL: Cystic fibrosis transmembrane conductance regulator knockout mice exhibit aberrant gastrointestinal microbiota. Gut Microbes 2013;4:41-47.
82. Werch R, Jung W, Day AA, Friedemann TE, Ivy AC: The decomposition of pectin and galacturonic acid by intestinal bacteria. The Journal of Infectious Diseases 1942;70:231-242.
83. Gerritsen J, Smidt H, Rijkers GT, de Vos WM: Intestinal microbiota in human health and disease: The impact of probiotics. Genes Nutr 2011;6:209-240.
84. Rongvaux A, Takizawa H, Strowig T, Willinger T, Eynon EE, Flavell RA, Manz MG: Human hemato-lymphoid system mice: Current use and future potential for medicine. Annu Rev Immunol 2013;31:635-674.
85. Kostic AD, Howitt MR, Garrett WS: Exploring host-microbiota interactions in animal models and humans. Genes Dev 2013;27:701-718.
86. Cho I, Blaser MJ: The human microbiome: At the interface of health and disease. Nat Rev Genet 2012;13:260-270.
87. Mead G: Bacteria in the gastrointestinal tract of birds. Gastrointestinal Microbiology 1997;2:216-240.
88. Meimandipour A, Shuhaimi M, Hair-Bejo M, Azhar K, Kabeir BM, Rasti B, Yazid AM: In vitro fermentation of broiler cecal content: The role of lactobacilli and pH value on the composition of microbiota and end products fermentation. Lett Appl Microbiol 2009;49:415-420.
89. Zhu XY, Zhong T, Pandya Y, Joerger RD: 16s rRNA-based analysis of microbiota from the cecum of broiler chickens. Appl Environ Microbiol 2002;68:124-137.
90. Schrezenmeir J, de Vrese M: Probiotics, prebiotics, and synbiotics-approaching a definition. Am J Clin Nutr 2001;73:361S-364S.
91. Marteau P, Boutron-Ruault MC: Nutritional advantages of probiotics and prebiotics. Br J Nutr 2002;87:S153-157.
92. Szilagyi A: Altered colonic environment, a possible predisposition to colorectal cancer and colonic inflammatory bowel disease: Rationale of dietary manipulation with emphasis on disaccharides. Can J Gastroenterol 1998;12:133-146.
93. Dai D, Walker WA: Protective nutrients and bacterial colonization in the immature human gut. Adv Pediatr 1999;46:353-382.
94. Fooks LJ, Gibson GR: Probiotics as modulators of the gut flora. Br J Nutr 2002;88:S39-49.
95. Fooks LJ, Gibson GR: In vitro investigations of the effect of probiotics and prebiotics on selected human intestinal pathogens. FEMS Microbiol Ecol 2002;39:67-75.
96. Ng SC, Hart AL, Kamm MA, Stagg AJ, Knight SC: Mechanisms of action of probiotics: Recent advances. Inflamm Bowel Dis 2009;15:300-310.
97. Gibson GR, Wang X: Regulatory effects of bifidobacteria on the growth of other colonic bacteria. J Appl Bacteriol 1994;77:412-420.
98. Hudault S, Lievin V, Bernet-Camard MF, Servin AL: Antagonistic activity exerted in vitro and in vivo by Lactobacillus casei (strain GG) against Salmonella typhimurium C5 infection. Appl Environ Microbiol 1997;63:513-518.
99. Fanaro S, Boehm G, Garssen J, Knol J, Mosca F, Stahl B, Vigi V: Galacto-oligosaccharides and long-chain fructo-oligosaccharides as prebiotics in infant formulas: A review. Acta Paediatr Suppl 2005;94:22-26.
100. Fanaro S, Jelinek J, Stahl B, Boehm G, Kock R, Vigi V: Acidic oligosaccharides from pectin hydrolysate as new component for infant formulae: Effect on intestinal flora, stool characteristics, and pH. J Pediatr Gastroenterol Nutr 2005;41:186-190.
101. Perez-Cobas AE, Gosalbes MJ, Friedrichs A, Knecht H, Artacho A, Eismann K, Otto W, Rojo D, Bargiela R, von Bergen M, Neulinger SC, Daumer C, Heinsen FA, Latorre A, Barbas C, Seifert J, Dos Santos VM, Ott SJ, Ferrer M, Moya A: Gut microbiota disturbance during antibiotic therapy: A multi-omic approach. Gut 2012
102. Zhang H, DiBaise JK, Zuccolo A, Kudrna D, Braidotti M, Yu Y, Parameswaran P, Crowell MD, Wing R, Rittmann BE, Krajmalnik-Brown R: Human gut microbiota in obesity and after gastric bypass. Proc Natl Acad Sci USA 2009;106:2365-2370.
103. Samuel BS, Gordon JI: A humanized gnotobiotic mouse model of host-archaeal-bacterial mutualism. Proc Natl Acad Sci USA 2006;103:10011-10016.
104. Fierer N, Jackson JA, Vilgalys R, Jackson RB: Assessment of soil microbial community structure by use of taxon-specific quantitative PCR assays. Appl Environ Microbiol 2005;71:4117-4120.
105. Guo X, Xia X, Tang R, Zhou J, Zhao H, Wang K: Development of a real-time PCR method for Firmicutes and Bacteroidetes in faeces and its application to quantify intestinal population of obese and lean pigs. Lett Appl Microbiol 2008;47:367-373.
106. Lee J, Kim S, Jung J, Oh B, Kim I, Hong S: Analysis of total bacteria, enteric members of y-proteobacteria and microbial communities in seawater as indirect indicators for quantifying biofouling. Environmental Engineering Research 2009;14 please double-check format of journal title
107. Collado MC, Donat E, Ribes-Koninckx C, Calabuig M, Sanz Y: Specific duodenal and faecal bacterial groups associated with paediatric coeliac disease. J Clin Pathol 2009;62:264-269.
108. Dalwai F, Spratt DA, Pratten J: Use of quantitative PCR and culture methods to characterize ecological flux in bacterial biofilms. J of Clin Microbiol 2007;45:3072-3076.